
Cynata
An Australian clinical-stage stem cell and regenerative medicine company focused on the development of therapies based on a proprietary therapeutic stem cell platform technology.
Market cap
$32.3m
Enterprise value
$25m
Share price
AUD0.21 CYP.AX
Authorizing premium user...